Merger Completed
Radius Health and Paratek Pharmaceuticals merger
Advisers
Paratek Pharmaceuticals
Target
Not disclosed
Acquirer
Not disclosed
Other advisers
- Legal adviser
- Target
- Paratek Pharmaceuticals
- Target based in
- United States
- Completed
- Mar 2026
- Sector
- Pharma
In the league tables
Similar deals
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Gilead acquisition of HCXT-2001 (investigational oral IL-23R inhibitor) Oct 2026 · Pharma
- US WorldMeds acquisition of Orbus Therapeutics Oct 2026 · Pharma
- DRI Healthcare Trust acquisition of Royalty participation rights in U.S. net sales of tavapadon Sep 2026 · US$316m · Specialty finance and leasing
- Grünenthal acquisition of Stivarga (regorafenib) Sep 2026 · US$433m · Pharma
Sources
- Mar 2026 Paratek Pharmaceuticals Combines With Radius Health skadden.com
